Several studies investigating the effects of FSH on metabolic risk factors including obesity, lipid and glucose metabolism, insulin resistance, lipid profiles and MetS are now being performed. The gene discussed is BRD2; the disease is obesity due to melanocortin 4 receptor deficiency.